JULIA MARIE EASTLAND
CIK 1500189 · CEO & President · last filed 2026-05-18
JULIA MARIE EASTLAND is a CEO & President who has filed 40 SEC Form 4 insider transactions across 8 companies since 2010. The most recent filing, for LNTH, was dated May 18, 2026. Across all open-market trades the lifetime net is +$28.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.14M
8
40
$28.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | Director | 8,019 | $104.52 | $838.1K | $0 | 3 | 2026-05-18 |
| ZNTL | CEO & President | 80,022 | $3.75 | $300.1K | $28.1K | 5 | 2026-02-10 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Director | 16,071 | $15.50 | $249.1K | $0 | 5 | 2024-05-28 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | President and CEO | 269,381 | $23.01 | $6.20M | $0 | 10 | 2024-03-11 |
| CALC | Director | 1,429 | $0.87 | $1.2K | $0 | 1 | 2023-03-27 |
| CalciMedica, Inc. (GRAY) Delisted | Director | — | $5.50 | — | $0 | 3 | 2022-06-03 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | CFO & CBO | 5,237 | — | — | $0 | 4 | 2018-02-02 |
| Cascadian Therapeutics, Inc. (ONTY) Delisted | CFO & VP Corp. Dev. | 20,016 | — | — | $0 | 8 | 2016-05-19 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | LNTH | Grant (A) | +4,137 | $0 | EDGAR |
| 2026-02-10 | ZNTL | Sell (S) | −8,755 | -$21.2K | EDGAR |
| 2026-01-09 | ZNTL | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | LNTH | Grant (A) | +2,537 | $0 | EDGAR |
| 2025-02-05 | ZNTL | Grant (A) | +59,388 | $0 | EDGAR |
| 2025-02-04 | ZNTL | Buy (P) | +28,500 | $49.3K | EDGAR |
| 2024-12-03 | ZNTL | Grant (A) | — | $0 | EDGAR |
| 2024-09-12 | LNTH | Grant (A) | +1,345 | $0 | EDGAR |
| 2024-05-28 | DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | Grant (A) | +5,357 | $0 | EDGAR |
| 2024-03-11 | Harpoon Therapeutics, Inc. (HARP) Delisted | Mixed | −238,131 | $0 | EDGAR |